Approach to Diagnosis
Distinguishing myopathies from peripheral neuropathies, anterior horn cell diseases (e.g. motor neurone disease) and neuromuscular junction disorders (e.g. myasthenic syndromes) requires careful clinical evaluation supplemented by investigations including neurophysiological testing, imaging, muscle biopsy and genetic exploration.
Determining aetiology of a myopathy depends upon a careful history and examination to elicit distinguishing features, including family history, age of onset and the rate of progression (including eliciting if symptoms are persistent or episodic), and the presence of additional features such as muscle aching and pain (myalgia) or urine turning black (myoglobinuria). Any provoking or relieving factors should be noted. From examination, the pattern of muscle involvement (facial, bulbar and, if involving limbs, whether proximal or distal and symmetric or asymmetric) will give further clues as will additional examination findings such as wasting, pseudo-hypertrophy, delayed relaxation after voluntary contraction (myotonia) and involuntary, spontaneous quivering of muscle bundles (myokymia).
Many of the above-mentioned muscle diseases are outside the scope of this book. The important acquired muscle diseases, however, include the inflammatory myopathies which are treatable and are covered in more detail in the following section. Remember neurologists are often asked to assess patients with weakness, where this is found to be secondary to ageing, immobility, critical illness or cancer.
The Treatable Inflammatory Mmyopathies
Definition
Polymyositis is a progressive inflammatory striated muscle disease in adults involving proximal muscles symmetrically in limbs, trunk, pharyngeal and oesophageal muscles.
Dermatomyositis is characterised by symptoms of polymyositis as well as cutaneous involvement.
